EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer: review proposal
Review of NICE Diagnostics Guidance No. DG9; EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer
Proposal to transfer the existing guidance to the static list.
The review of the above diagnostics guidance was launched in August 2016.
Changes in clinical practice, technology costs or evidence that would lead to a change in the recommendations of the original guidance have not been identified. It is therefore proposed that the guidance is placed on the static list.
In order to be completely confident that this is appropriate, we are asking all relevant registered stakeholders to inform us of any evidence which will help us decide the best way to update this guidance.
Comments must be submitted to Diagnostics@nice.org.uk by 5pm, 13 February 2017.
This page was last updated: